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ABSTRACT
Using monospecific fluorescent antisera in an FTA-ABS procedure, it was possible to
determine the immurioglobulin class of anti-T. pallidum antibodies present in sera of
66 patients treated 13 or more years ago for latent or late syphilis. A significant amount
of IgG reactivity was present in all scm, whereas 1gM antibody was found in only 47%,
and in these it was of lesser magnitude than the IgG antibody. The presence of 1gM
reactivity showed no absolute correlation with reactivity in TPI or cardiolipin tests,
years since therapy, age of patient, or presence of serum antiglobulin factors. IgA
antibody was detected in only one serum.
We recently reported that 66 of 67 patients
diagnosed and treated 13 or more years ago
for latent or late syphilis were reactive in the
Fluorescent Treponemal Antibody-Absorption
(FTA-ABS) test (1). We report here a charac-
terization of the immunoglobulin class of this
reactivity.
MATERIALS AND METHODS
Sera were obtained in 1966 from 67 patients
diagnosed and treated 13 or more years ago for
latent or late syphilis. The present study was
performed on those 66 sera reactive in the FTA-
ABS test. The sera had been stored at __200 C
until tested. Details of the clinical and serological
status of the patients in 1950—52, and in the 1966
follow-up, were presented previously (1).
The indirect fluorescent antibody (FA) assay
was modeled on the FTA-ABS technique (2).
The immunoglobulin class of antibody which
attached to the treponeme was revealed by stain-
ing with fluorescein-conjugated goat antiserum to
human IgG, IgA, and 1gM. The evidence for the
monospecificity of these reagents has been pre-
sented elsewhere (3). Throughout this study the
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specificity of the FA conjugate used in the FTA-
ABS test was denoted in parentheses; viz., FTA-
ABS (IgG), FTA-ABS (IgA), and FTA-ABS
(1gM). Appropriate controls were included.
Serum antiglobulin (rheumatoid factor) factors
were assayed on a slide using latex particles
sensitized with human gamma globulin (RA test;
Hyland) as antigen. Reactivity at 1:20 dilution
or higher was considered positive.
RESULTS
The data in Table I indicate that there is
strong FTA-ABS (IgG) antibody present in
all patients; FTA-ABS (1gM) antibody was
present to a lesser extent in 31 patients (47%)
only one patient had detectable FTA-ABS
(IgA) antibody. FTA-ABS (1gM) reactivity
was found in all diagnostic categories studied
(Table II). No relationship existed between
FTA-ABS (1gM) reactivity and age of pa-
tient, years since therapy, or reactivity in the
Treponema pallidum immobilization (TPI) or
cardiolipin tests. The patient group as a whole
was an older one. All patients had received
penicillin therapy except four, who had received
heavy metals. Of these four, only two showed
FTA-ABS (1gM) reactivity.
Since it is reported that antiglobulin (rheu-
matoid) factors are more prevalent in older
persons and in syphilitics (4, 5), it was of
interest to determine the association of reac-
tive rheumatoid factor test with FTA-ABS
(1gM) reactivity. Antiglobulin reactivity was
demonstrable in patients with F1A-ABS (1gM)
reactivity, as well as in those who were non-
reactive, but it was more prevalent in the
former group.
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TABLE I
Immuno'lobulin class of serum antibodies reactive
with Treponema pallidum in the
FTA-ABS procedure
Degree of reactivity
SpeciScity of fluorescein-con-jugated antiserum
IgG 1gM IgA
3+, 4+
2+
1+
N,±
66*
—
—
—
11
5
15
35
—
1
65
* Number of patients.
TABLE II
Helation of FTA-ABS (IgM)* reactivity to
diagnostic category
Patient category Numbertested
Number PTA-
ABS (15M)*
reactive
Early latent
Late latent
Tertiary
Congenital
All patients
4
45
12
5
66
1
19
8
3
31
* Modified FTA-ABS
monospecific for 1gM.
test using FA reagent
DISCUSSION
If therapy is not administered until the late
stages of syphilis the TPI and FTA-ABS tests
will remain reactive for many years, and possi-
bly for life (1, 6). But the intricate nature of
the TPI test makes it difficult to determine
the immunoglobulin class of antibodies respon-
sible for the continued reactivity. In contrast,
through the use of monospecific FA reagents
in a modified FTA-ABS test, one can work with
whole serum and readily determine the im-
munoglobulin class of the antibody reactive
with even a few treponemes. The present
study makes it clear that TgG antibodies com-
prise the bulk of the persistent FTA-ABS test
reactivity we reported previously (1). It remains
to be determined why only a proportion of the
patients shows FTA-ABS (1gM) reactivity.
Since we worked with whole sera, it is possible
that competition between IgG and 1gM anti-
bodies worked to diminish detection of 1gM
reactivity (7).
REFERENCES
1. Atwood, W. G., Miller, J. L., Stout, G. W. and
Norms, L. C.: The TPI and FI'A-ABS tests
in treated late syphilis. J.A.MA., 203: 549,
1968.
2. Staff, Venereal Disease Research Laboratory:
Manual of Tests for ,Syphilzs 1969, PHS Pub-
lication No. 411 (revised January 1969), U.S.
Department of Health, Education, and Wel-
fare, Government Printing Office, Washington,
D.C. 20402.
3. Julian, A. J., Logan, L. C. and Norms, L. C.:
Early syphilis: Immunoglobulins reactive in
immunofluorescence and other serologic tests.
J. Immun., 102: 1250, 1969.
4. Mustakallio, K. K., Lassus, A. and Wagner, 0.:
Auto-immune phenomena in syphilitic in-
fection. Tat. Arch. Allerg., 81: 417, 1967.
5. Peltier, A. and Christian, C. L.: The presence
of the rheumatoid factor in sera from pa-
tients with syphilis. Arth. Rheum., 2: 1, 1959.
6. Olansky, S., Harris, A. and Price, E. V.: TPI
test in treated syphilis. Brit. J. Vener. Dis.,
32: 104, 1956.
7. Cohen, I. R., Norms, L. C. and Julian, A. J.:
Competition between, and effectiveness of,
IgG and 1gM antibodies in indirect fluo-
rescent antibody and other tests. J. Immun.,
98: 143, 1966.
